Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Medicine (Baltimore) ; 100(19): e25771, 2021 May 14.
Artículo en Inglés | MEDLINE | ID: covidwho-2190997

RESUMEN

INTRODUCTION: Corona virus disease-2019 (COVID-19) presents primarily with respiratory symptoms. However, extra respiratory manifestations are being frequently recognized including gastrointestinal involvement. The most common gastrointestinal symptoms are nausea, vomiting, diarrhoea and abdominal pain. Gastrointestinal perforation in association with COVID-19 is rarely reported in the literature. PATIENT CONCERNS AND DIAGNOSIS: In this series, we are reporting 3 cases with different presentations of gastrointestinal perforation in the setting of COVID-19. Two patients were admitted with critical COVID-19 pneumonia, both required intensive care, intubation and mechanical ventilation. The first one was an elderly gentleman who had difficult weaning from mechanical ventilation and required tracheostomy. During his stay in intensive care unit, he developed Candidemia without clear source. After transfer to the ward, he developed lower gastrointestinal bleeding and found by imaging to have sealed perforated cecal mass with radiological signs of peritonitis. The second one was an obese young gentleman who was found incidentally to have air under diaphragm. Computed tomography showed severe pneumoperitoneum with cecal and gastric wall perforation. The third case was an elderly gentleman who presented with severe COVID-19 pneumonia along with symptoms and signs of acute abdomen who was confirmed by imaging to have sigmoid diverticulitis with perforation and abscess collection. INTERVENTIONS: The first 2 cases were treated conservatively. The third one was treated surgically. OUTCOME: Our cases had a variable hospital course but fortunately all were discharged in a good clinical condition. CONCLUSION: Our aim from this series is to highlight this fatal complication to clinicians in order to enrich our understanding of this pandemic and as a result improve patients' outcome.


Asunto(s)
COVID-19/complicaciones , Tracto Gastrointestinal/lesiones , Rotura Espontánea/etiología , Adulto , Anciano , Cuidados Críticos/organización & administración , Humanos , Masculino , Pandemias , Recto/lesiones , SARS-CoV-2 , Estómago/lesiones
2.
IUBMB Life ; 74(1): 62-73, 2022 01.
Artículo en Inglés | MEDLINE | ID: covidwho-1850068

RESUMEN

Airborne pollution has become a leading cause of global death in industrialized cities and the exposure to environmental pollutants has been demonstrated to have adverse effects on human health. Among the pollutants, particulate matter (PM) is one of the most toxic and although its exposure has been more commonly correlated with respiratory diseases, gastrointestinal (GI) complications have also been reported as a consequence to PM exposure. Due to its composition, PM is able to exert on intestinal mucosa both direct damaging effects, (by reaching it either via direct ingestion of contaminated food and water or indirect inhalation and consequent macrophagic mucociliary clearance) and indirect ones via generation of systemic inflammation. The relationship between respiratory and GI conditions is well described by the lung-gut axis and more recently, has become even clearer during coronavirus disease 2019 (COVID-19) pandemic, when respiratory symptoms were associated with gastrointestinal conditions. This review aims at pointing out the mechanisms and the models used to evaluate PM induced GI tract damage.


Asunto(s)
COVID-19/etiología , Tracto Gastrointestinal/lesiones , Material Particulado/toxicidad , SARS-CoV-2 , Administración por Inhalación , Administración Oral , COVID-19/fisiopatología , COVID-19/prevención & control , Tracto Gastrointestinal/fisiopatología , Humanos , Mucosa Intestinal/lesiones , Mucosa Intestinal/fisiopatología , Máscaras , Microplásticos/toxicidad , Modelos Biológicos , Depuración Mucociliar/fisiología , Política Nutricional , Pandemias/prevención & control , Material Particulado/administración & dosificación , Sistema Respiratorio/lesiones , Sistema Respiratorio/fisiopatología
3.
Signal Transduct Target Ther ; 5(1): 256, 2020 11 02.
Artículo en Inglés | MEDLINE | ID: covidwho-899906

RESUMEN

Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is spreading globally and poses a huge threat to human health. Besides common respiratory symptoms, some patients with COVID-19 experience gastrointestinal symptoms, such as diarrhea, nausea, vomiting, and loss of appetite. SARS-CoV-2 might infect the gastrointestinal tract through its viral receptor angiotensin-converting enzyme 2 (ACE2) and there is increasing evidence of a possible fecal-oral transmission route. In addition, there exist multiple abnormalities in liver enzymes. COVID-19-related liver injury may be due to drug-induced liver injury, systemic inflammatory reaction, and hypoxia-ischemia reperfusion injury. The direct toxic attack of SARS-CoV-2 on the liver is still questionable. This review highlights the manifestations and potential mechanisms of gastrointestinal and hepatic injuries in COVID-19 to raise awareness of digestive system injury in COVID-19.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/epidemiología , Infecciones por Coronavirus/epidemiología , Enfermedades Gastrointestinales/epidemiología , Hepatopatías/epidemiología , Neumonía Viral/epidemiología , Enzima Convertidora de Angiotensina 2 , COVID-19 , Enfermedad Hepática Inducida por Sustancias y Drogas/genética , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Enfermedad Hepática Inducida por Sustancias y Drogas/virología , Infecciones por Coronavirus/genética , Infecciones por Coronavirus/patología , Infecciones por Coronavirus/virología , Heces/virología , Enfermedades Gastrointestinales/complicaciones , Enfermedades Gastrointestinales/genética , Enfermedades Gastrointestinales/virología , Tracto Gastrointestinal/lesiones , Tracto Gastrointestinal/patología , Tracto Gastrointestinal/virología , Humanos , Hígado/fisiopatología , Hígado/virología , Hepatopatías/genética , Hepatopatías/patología , Hepatopatías/virología , Pandemias , Peptidil-Dipeptidasa A/genética , Neumonía Viral/genética , Neumonía Viral/patología , Neumonía Viral/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA